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CONTROLLED TRIALS 
Dino Samartzis, DSc, PhD (C), MSc; Patrick Vavken; Hitesh N. Modi, MS, PhD; Keith D. Luk, 
MD;Kenneth M. Cheung, MBBS(UK), FRCS(England), FHKCOS, FHKAM(Orth) China 
 
 
SUMMARY: A meta-analysis of the literature was performed to assess the development of 
adjacent segment degeneration/disease between cervical disc arthroplasty (CDA) to that of 
anterior cervical discectomy and fusion (ACDF) at 2 and 4 year follow-up periods. Due to 
weaknesses in study design, heterogeneity in management, and relatively high withdrawal/drop-
out rates, robust conclusions supporting the advocacy of CDA over ACDF cannot be made at this 
stage. 
 
INTRODUCTION: To reduce the risk of adjacent segment disease and other procedurerelated 
complications following anterior cervical discectomy and fusion (ACDF), cervical disc 
arthroplasty (CDA) has been advocated for one-level cervical disc disease. However, it remains 
unknown whether CDA decreases the occurrence of such complications. As such, the following 
study addressed a meta-analysis of randomized controlled trials assessing the efficacy of CDA in 
reducing adjacent segment disease and other complications in comparison to ACDF. 
 
METHODS: Three reviewers performed a literature search for randomized controlled trials 
comparing CDA to ACDF for radiculopathy and/or myelopathy for one-level cervical disc 
disease. Studies with 2 years or greater follow-up were selected. Adjacent segment disease, 
secondary surgery (i.e. revision, reoperation, instrumentation/graft removal), and adverse events 
were assessed and pooled for analyses. 
 
RESULTS: Eight studies were included for review. Due to limitations with study design, studies 
presented with Level II evidence. CDA exhibited a decrease risk for reoperation attributed to 
adjacent segment disease, but was not statistically significant (p>0.05). Additional procedure-
related complications did not statistically differ between groups (p>0.05). 
 
CONCLUSION: Up to 4 year follow-up, CDA does not significantly reduce the risk of adjacent 
segment disease and other complications in comparison to ACDF. Due to the lack of blinding, 
variation in surgical management, and relatively high withdrawal/dropout rates among studies at 
2 and 4 year follow-up, robust conclusions supporting the advocacy of CDA over ACDF cannot 
be made at this stage. High-quality studies are needed to properly assess the true efficacy of such 
interventions. 
